Gensight Biologics SA (SIGHT) Stock Price & News

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	302.00K	302.00K	-428.00K	-428.00K
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	1.08M	1.08M	2.34M	2.34M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.36M	1.36M	1.50M	1.50M
Operating expense	2.43M	2.43M	3.84M	3.84M
Total operating expenses	2.43M	2.43M	3.84M	3.84M
Operating income	-2.13M	-2.13M	-4.27M	-4.27M
Other non operating income	436.00K	436.00K	-285.50K	-285.50K
EBT including unusual items	-2.53M	-2.53M	-5.14M	-5.14M
EBT excluding unusual items	-2.53M	-2.53M	-5.14M	-5.14M
Income tax expense	2.00K	2.00K	500.00	500.00
Effective tax rate	-0.08%	-0.08%	-0.01%	-0.01%
Other operating expenses	-	-	-	-
Net income	-2.53M	-2.53M	-5.14M	-5.14M
Net profit margin	-839.24%	-839.24%	1,199.88%	1,199.88%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-784.50K	-784.50K	-578.00K	-578.00K
Net interest expenses	-784.50K	-784.50K	-578.00K	-578.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-2.09M	-2.09M	-4.24M	-4.24M
Gain or loss from assets sale	-	-	-	-

Finance